Close Menu

Precision Oncology Business, Policy & Funding

Breaking news on Precision Oncology business, policy & funding.

The pavilion and precision medicine programs are supported by $40 million in philanthropic funding from Mort Harris in honor of his late wife Brigitte.

On Thursday, Predictive Oncology closed another direct offering initiated earlier in the week, raising $2.2 million.

The partnership aims to develop a test that will determine which patients with advanced colorectal cancer will not respond to standard treatment.

The EMA granted conditional approval based on the drug's ability to shrink tumors in 61 percent of patients in the Phase II DESTINY-Breast01 trial.